accessibility menu, dialog, popup

UserName
Viewing profile as user:

Fluorobenzenes

Organic compounds considered aryl halides that consist of a phenyl group with a fluorine atom substitution in the following structure: C₆H₅F.
Molecular Weight (g/mol) 
  • (2)
  • (2)
Percent Purity 
  • (2)
  • (2)
Physical Form 
  • (2)
  • (2)
Quantity 
  • (1)
  • (2)
  • (1)

Filtered Search Results

Products from some of our suppliers do not display in filtered search results. Please clear all filters to see these products.

Narrow Results

Narrow Results

category

brands

  • (2)
  • (1)
  • (1)
  • (4)
  • (4)
  • (1)

special interests

  • (8)

Molecular Weight (g/mol)

  • (2)
  • (2)

Percent Purity

  • (2)
  • (2)

Physical Form

  • (2)
  • (2)

Quantity

  • (1)
  • (2)
  • (1)

Search Within Results
Keyword Search:
1 – 11 of 11 results
1

3,4-Difluoroaniline 98.0+%, TCI America™

CAS: 3863-11-4 Molecular Formula: C6H5F2N Molecular Weight (g/mol): 129.11 MDL Number: MFCD00007761 InChI Key: AXNUZKSSQHTNPZ-UHFFFAOYSA-N Synonym: 3,4-difluorobenzenamine,benzenamine, 3,4-difluoro,3,4-difluoro-phenylamine,3,4-difluorophenyl amine,3,4-difluoro aniline,3,4-difluorophenylamine,3,4-difluoranilin,3,4-difloroaniline,3,4-difluroaniline,3.4-difluoroaniline PubChem CID: 77469 IUPAC Name: 3,4-difluoroaniline SMILES: C1=CC(=C(C=C1N)F)F

PubChem CID 77469
CAS 3863-11-4
Molecular Weight (g/mol) 129.11
MDL Number MFCD00007761
SMILES C1=CC(=C(C=C1N)F)F
Synonym 3,4-difluorobenzenamine,benzenamine, 3,4-difluoro,3,4-difluoro-phenylamine,3,4-difluorophenyl amine,3,4-difluoro aniline,3,4-difluorophenylamine,3,4-difluoranilin,3,4-difloroaniline,3,4-difluroaniline,3.4-difluoroaniline
IUPAC Name 3,4-difluoroaniline
InChI Key AXNUZKSSQHTNPZ-UHFFFAOYSA-N
Molecular Formula C6H5F2N
2

3-Bromo-4-fluorophenylacetic Acid 97.0+%, TCI America™

CAS: 194019-11-9 Molecular Formula: C8H6BrFO2 Molecular Weight (g/mol): 233.04 MDL Number: MFCD04038373 InChI Key: XXFGIJYSXNXNAU-UHFFFAOYSA-N Synonym: 3-bromo-4-fluorophenylacetic acid,2-3-bromo-4-fluorophenyl acetic acid,3-bromo-4-fluorophenylaceticacid,3-bromo-4-fluorophenyl acetic acid,benzeneacetic acid, 3-bromo-4-fluoro,3-bromo-4-fluoro-phenyl-acetic acid,2-3-bromo-4-fluoro-phenyl acetic acid,acmc-209exn,ksc497i4b,61150-59-2 3-bromo-4-fluorophenylacetic acid PubChem CID: 3416339 IUPAC Name: 2-(3-bromo-4-fluorophenyl)acetic acid SMILES: OC(=O)CC1=CC(Br)=C(F)C=C1

PubChem CID 3416339
CAS 194019-11-9
Molecular Weight (g/mol) 233.04
MDL Number MFCD04038373
SMILES OC(=O)CC1=CC(Br)=C(F)C=C1
Synonym 3-bromo-4-fluorophenylacetic acid,2-3-bromo-4-fluorophenyl acetic acid,3-bromo-4-fluorophenylaceticacid,3-bromo-4-fluorophenyl acetic acid,benzeneacetic acid, 3-bromo-4-fluoro,3-bromo-4-fluoro-phenyl-acetic acid,2-3-bromo-4-fluoro-phenyl acetic acid,acmc-209exn,ksc497i4b,61150-59-2 3-bromo-4-fluorophenylacetic acid
IUPAC Name 2-(3-bromo-4-fluorophenyl)acetic acid
InChI Key XXFGIJYSXNXNAU-UHFFFAOYSA-N
Molecular Formula C8H6BrFO2
3

eMolecules​ Medchem Express / GSK-3 inhibitor 11 / 5mg / 736631181 / HY-148132 / / 536731-65-4 / [null] / 393.420 / C20H15N3O4S

Medchem Express / GSK-3 inhibitor 11 / 5mg / 736631181 / HY-148132 / / 536731-65-4 / [null] / 393.420 / C20H15N3O4S

ENCOMPASS_PREFERRED
4

Accela Chembio Inc (8r | 9s | 10r | 13s | 14s)-10 | 13-dimethyl-7 | 8 | 9 | 11 | 12 | 13 | 15 | 16-octahydro-10h-cyclopenta[a]phenanthrene-3 | 6 | 17(14h)-trione | 1g | 72648-46-5 | MFCD19442767 | 95+% | Shelf Life: 1440 Days | Light Sensitive/+4
SDP

(8r | 9s | 10r | 13s | 14s)-10 | 13-dimethyl-7 | 8 | 9 | 11 | 12 | 13 | 15 | 16-octahydro-10h-cyclopenta[a]phenanthrene-3 | 6 | 17(14h)-trione | 1g | 72648-46-5 | MFCD19442767 | 95+% | Shelf Life: 1440 Days | Light Sensitive/+4

ENCOMPASS_PREFERRED
5

Accela Chembio Inc (8r | 9s | 10r | 13s | 14s)-10 | 13-dimethylspiro[7 | 8 | 9 | 11 | 12 | 13 | 15 | 16-octahydro-6h-cyclopenta[a]phenanthrene-6 | 2'-oxirane]-3 | 17(10h | 14h)-dione | 1g | 184972-12-1 | MFCD19442795 | 97+% | Shelf Life: 1260 Days | Light Sensitive/+4
SDP

(8r | 9s | 10r | 13s | 14s)-10 | 13-dimethylspiro[7 | 8 | 9 | 11 | 12 | 13 | 15 | 16-octahydro-6h-cyclopenta[a]phenanthrene-6 | 2'-oxirane]-3 | 17(10h | 14h)-dione | 1g | 184972-12-1 | MFCD19442795 | 97+% | Shelf Life: 1260 Days | Light Sensitive/+4

ENCOMPASS_PREFERRED
6

Indofine Chemical 3,4-Difluoroanili, 98%, 100 Gm
SDP

3,4-DIFLUOROANILINE 100 GM, Fluoro Organics, C6H5F2N, MW: 129.11, 0.98, 3863-11-4, MFCD00007761

ENCOMPASS_PREFERRED
7

Medchemexpress LLC Cdk9-in-7 | 2369981-71-3 | 98.1% | 547.71 g·mol⁻¹ | C29H37N7O2S | 10MG
SDP

CDK9-IN-7 is a selective, potent small-molecule inhibitor of cyclin-dependent kinase 9 (CDK9) intended for research use. It exhibits nanomolar potency (IC50 ≈ 11 nM) and has been reported to induce apoptosis and cell-cycle arrest in cancer cell models. Supplied as a powder, it is suitable for preclinical assays and mechanistic studies.

  • Selective CDK9 inhibition with reported IC50 ≈ 11 nM.
  • High purity approximately 98.1% suitable for research assays.
  • Molecular formula C29H37N7O2S and molecular weight 547.71 g·mol⁻¹.
  • Provided as a powder form, typically available in 10 mg quantity.
  • Recommended storage: powder -20°C (long term) or 4°C (short term).
  • Common applications include cell cycle, apoptosis, and transcriptional regulation studies.

ENCOMPASS_PREFERRED
8

Medchemexpress LLC HY-10329 2mg Medchemexpress, JNJ-7706621 CAS:443797-96-4 Purity:>98%
SDP

Medchemexpress, HY-10329 2mg JNJ-7706621 CAS:443797-96-4 JNJ-7706621 is a potent aurora kinase inhibitor, and also inhibits CDK1 and CDK2, with IC50s of 9, 3, 11, and 15 nM for CDK1, CDK2, Aurora-A and Aurora-B, respectively. Purity:>98% Medchemexpress has over 10000 novel life-science reagents, reference compounds, APIs and natural compounds for laboratory and scientific use. Other quantity can also be offered.

ENCOMPASS_PREFERRED
9

Apexbio Technology LLC TAK-632 1228591-30-7 5mg
SDP

TAK-632 (CAS 1228591-30-7) is a selective inhibitor of RAF kinase isoforms including BRAF CRAF and the mutant BRAF-V600E exhibiting IC50 values of 8 3 nM 1 4 nM and 2 4 nM respectively By targeting the RAF family of serine/threonine kinases TAK-632 disrupts the RAS-RAF-MEK-ERK signaling pathway implicated in MAPK cascade regulation In cellular assays TAK-632 promotes BRAF-CRAF dimerization and demonstrates potent antiproliferative effects in A375 and SK-MEL-2 melanoma cell lines with GI50 values of 6 nM and 11 nM respectively In vivo oral administration in SK-MEL-2 xenograft models inhibits ERK phosphorylation and tumor growth without notable toxicity TAK-632 is suitable for investigating RAF-driven signaling and drug resistance in oncogenic pathway studies

ENCOMPASS_PREFERRED
10

Medchemexpress LLC 7-cyclopentyl-2-[4-(8-isothiocyanatooctanoylamino)anilino]-N,N-dimethylpyrrolo[2,3-d]pyrimidine-6-ca | 2369981-71-3 | 98.1% | 547.71 | C29H37N7O2S | 50MG
SDP

CDK9-IN-7 is a selective, potent cyclin-dependent kinase 9 (CDK9) inhibitor (compound 21e) used for cell-cycle and apoptosis research. It exhibits low-nanomolar inhibitory activity and is supplied as a high-purity research reagent in powder and solution formats.

  • Selective CDK9 inhibition with IC50 ≈ 11 nM.
  • Low nanomolar potency suitable for in vitro and in vivo studies.
  • High purity (≈98.1%).
  • Available as powder and as a 10 mM solution in DMSO.
  • Multiple package sizes, including a 50 mg option.
  • Recommended storage: powder at -20°C (long term) or 4°C; in solvent at -80°C for extended storage.

ENCOMPASS_PREFERRED
11

Medchemexpress LLC BSJ-02-162 (CDK4/6-IN-11) | 2139329-47-6 | 98.1% | C43H49N11O7 | 10MG
SDP

BSJ-02-162 (CDK4/6-IN-11) is a proteolysis-targeting chimera (PROTAC) developed for preclinical research to induce ubiquitin-mediated degradation of cyclin-dependent kinases 4 and 6. The molecule combines an E3 ligase-recruiting thalidomide-derived moiety with a palbociclib-derived target ligand connected by a modular linker to promote selective proteasomal degradation of CDK4/6.

  • Induces targeted degradation of CDK4 and CDK6 via PROTAC mechanism.
  • High chemical purity suitable for research applications.
  • Available as a solid powder with recommended cold storage.
  • Soluble in DMSO at high concentration; ultrasonic assistance may be required.
  • Supplied in multiple small pack sizes for screening and optimization.

ENCOMPASS_PREFERRED